Latest Research Reports

The global burden of rheumatoid arthritis will increase

The global burden of rheumatoid arthritis will increase

Orphan cancer drugs take up 37% of market share

Orphan cancer drugs take up 37% of market share

Report: Growth hormone deficiency market to surpass $2bn by 2026

The global growth hormone deficiency (GHD) market is expected to grow from $1.42bn in 2016 to $2.08bn by 2026 at a compound annual growth rate (CAGR) of 3.9%, according to a report by...

Report: Growth hormone deficiency market to surpass $2bn by 2026

US and UK stand out with higher disease prevalence of two autoimmune diseases

US and UK stand out with higher disease prevalence of two autoimmune diseases

The launch of long-acting therapies will drive the growth of the growth hormone deficiency Market

The launch of long-acting therapies will drive the growth of the growth hormone deficiency Market

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Report: German pharmaceuticals market set to grow at CAGR of 4.9% by 2021

The German pharmaceuticals market is expected to grow from €52.9bn ($67.9bn) in 2016 to €67.2bn ($86.3bn) in 2021, according to a report by...

Report: German pharmaceuticals market set to grow at CAGR of 4.9% by 2021

Cost containment remains strategic driver in outsourcing sector

Total combined peer group operating margin increased by 100 basis points to 12.4% of total sales in 2016, which represented three consecutive years of margin improvement in the outsourcing...

Cost containment remains strategic driver in outsourcing sector

Report: Spanish pharmaceutical market to witness modest growth rate of 1% by 2021

The Spanish pharmaceutical market is forecast to grow from $23.7bn in value in 2016 to $25.1bn by 2021, according to a report by...

Report: Spanish pharmaceutical market to witness modest growth rate of 1% by 2021

A look at atrial fibrillation’s market size forecast

A look at atrial fibrillation’s market size forecast

Industry-sponsored clinical trials initiated in Q1 2017

Industry-sponsored clinical trials initiated in Q1 2017

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Licensing deals in Duchenne Muscular Dystrophy (DMD)

Licensing deals in Duchenne Muscular Dystrophy (DMD)

China shows leading emerging market growth in R&D spend

While the global pharmaceutical markets have typically been dominated by US, Europe and Japan, emerging markets have been steadily increasing their prominence in the global space over the...

China shows leading emerging market growth in R&D spend

Top sponsors and CROs for 2012-2016 clinical trials in Israel

Top sponsors and CROs for 2012-2016 clinical trials in Israel

Innovative new drugs could produce a watershed moment for dermatology sufferers

Innovative new drugs could produce a watershed moment for dermatology sufferers

Rapid expansion of Biosimilar trials between 2007 and 2016

Rapid expansion of Biosimilar trials between 2007 and 2016

Pharma licensing deals 2016/2017 comparison

Pharma licensing deals 2016/2017 comparison

Report: Bladder cancer market to grow at CAGR of 12.5% up to 2025

The bladder cancer market is expected to triple in size from $360m in 2015 to $1.1bn by 2025, witnessing a compound annual growth rate (CAGR) of 12.5%, according to a report by...

Report: Bladder cancer market to grow at CAGR of 12.5% up to 2025

Inorganic growth continues to fuel outsourcing sector

Inorganic growth continues to fuel outsourcing sector